The WNBA has officially removed marijuana from its prohibited substances list while also laying out rules for how players can invest in and promote cannabis companies.
At the same time, however, the women’s basketball league is also adding several psychedelics to the list of banned drugs.
As part of negotiations between the Women’s National Basketball Players Association and WNBA earlier this year, the league offered to remove cannabis from its drug testing protocol. Now, under the terms of the long-form version of a new Collective Bargaining Agreement (CBA) signed by representatives of both sides, marijuana no longer appears on the prohibited substances list, whereas under the prior CBA it was included under “Drugs of Abuse.”
Prior WNBA policy treated cannabis significantly more restrictively compared to the NBA, as well as multiple other professional sports leagues beyond basketball that have also adopted reforms amid the state legalization movement. First-time offenses generally resulted in treatment referrals, but repeated violations could lead to fines and suspensions.
Under the new rules, players could still be subject to testing for cannabis if they enter the league’s Drugs of Abuse Program, if they are found to have been under the influence “while engaged in activities” for
Read full article on Marijuana Moment
